Remgro Ltd (STU:RE7)

Full Year 2025 Remgro Ltd Earnings Call Transcript

Sep 23, 2025 / 07:00 AM GMT

Release Date Price: €8.25 (+1.24%)

Transcript

Key Points

Positve

Remgro Ltd (FRA:RE7) reported a significant increase in headline earnings by 38.6%, reflecting strong performance across its portfolio.
The company declared a special dividend of 2 rand per share, utilizing proceeds from the sale of BAT shares.
Key portfolio companies like Mediclinic, Outsurance, RCL Foods, and Rainbow showed improved contributions, driving overall earnings growth.
Remgro Ltd (FRA:RE7) successfully reduced its debt, enhancing its financial flexibility for future capital allocation opportunities.
The company made progress in simplifying its portfolio, including the unbundling of E-Media investments and the disposal of shares in BAT and Grindrod.

Negative

The operating environment remains challenging with global trade tensions, geopolitical instability, and muted domestic growth impacting South African corporates.
Mediclinic faces regulatory challenges in Switzerland, which could threaten its sustained recovery.
Heineken Beverages is experiencing volume declines due to aggressive pricing trends in the beverages market.
CIVH reported a negative headline earnings result due to interest rate derivatives, despite underlying performance improvements.
The market dynamics in some key businesses continue to be challenging, requiring ongoing efforts to improve operational performance.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

REMJ.J - Remgro Ltd
Full Year 2025 Remgro Ltd Earnings Call
Sep 23, 2025 / 07:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning everybody.

Thank you for joining us this morning and welcome to our final results presentation for the year end at 30 June 2025.

Today, the team and I will unpack our financial performance for this past financial year, and it's become our set format, we'll delve into some detail on the performance of our key portfolio companies that contribute meaningful to our overall performance.

With that in mind, the outline of today's presentation will be as follows. First, myself and then Carl Foster will give an overview of the salient features of our results for the year.

Including a high-level recap of our key strate strategic priorities, which remains consistent with those that we communicated at our

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.